SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000880771-17-000079
Filing Date
2017-05-10
Accepted
2017-05-10 16:30:42
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20170331x10q.htm 10-Q 1227667
2 EX-10.1 scln-20170331xex10_1.htm EX-10.1 123157
3 EX-10.2 scln-20170331xex10_2.htm EX-10.2 124762
4 EX-10.3 scln-20170331xex10_3.htm EX-10.3 146146
5 EX-31.1 scln-20170331xex31_1.htm EX-31.1 18135
6 EX-31.2 scln-20170331xex31_2.htm EX-31.2 18311
7 EX-32.1 scln-20170331xex32_1.htm EX-32.1 12578
8 EX-32.2 scln-20170331xex32_2.htm EX-32.2 15269
  Complete submission text file 0000880771-17-000079.txt   4780524

Data Files

Seq Description Document Type Size
9 EX-101.INS scln-20170331.xml EX-101.INS 875106
10 EX-101.SCH scln-20170331.xsd EX-101.SCH 32989
11 EX-101.CAL scln-20170331_cal.xml EX-101.CAL 40464
12 EX-101.DEF scln-20170331_def.xml EX-101.DEF 77679
13 EX-101.LAB scln-20170331_lab.xml EX-101.LAB 235613
14 EX-101.PRE scln-20170331_pre.xml EX-101.PRE 197133
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 17830749
SIC: 2834 Pharmaceutical Preparations